WOLFGANG WINKELMAYER to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Diabetes Mellitus, Type 2.
Connection Strength
1.481
-
Black Race Coefficient in GFR Estimation and Diabetes Medications in CKD: National Estimates. J Am Soc Nephrol. 2021 06 01; 32(6):1319-1321.
Score: 0.368
-
Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus. J Am Heart Assoc. 2017 Jun 07; 6(6).
Score: 0.282
-
What caused excess strokes in patients randomized to darbepoetin in the trial to reduce cardiovascular events with Aranesp therapy (TREAT)?: no smoking gun. Circulation. 2011 Dec 20; 124(25):2805-8.
Score: 0.193
-
Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy-dependent type 2 diabetes mellitus in Austria. Pharmacoepidemiol Drug Saf. 2011 Jan; 20(1):57-65.
Score: 0.179
-
Cardiovascular risk and the thiazolidinediones: d?j? vu all over again? JAMA. 2007 Sep 12; 298(10):1216-8.
Score: 0.144
-
Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetes. Diabetes Care. 2006 Oct; 29(10):2210-7.
Score: 0.135
-
Cardiovascular outcomes associated with prescription of sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with diabetes and chronic kidney disease. Diabetes Obes Metab. 2022 05; 24(5):928-937.
Score: 0.098
-
Antidiabetic medication use in patients with type 2 diabetes and chronic kidney disease. J Diabetes Complications. 2019 11; 33(11):107423.
Score: 0.082